MYDGF and metabolic dysfunction-associated steatotic liver disease: In addition, the results of western blot (WB), reverse transcription-polymerase chain (RT-PCR), and immunofluorescent (IF) experiments showed that the MYDGF protein and mRNA expression levels were lower in the marrow of NAFLD mice than in control mice (Fig. 1C–E, P < 0.001).